We first started using BioNews when we launched a new product in the respiratory market. Using the news-based content and social media platform provided by BioNews helped drive awareness and demand for our product at both the clinical and consumer level at a much faster rate than conventional marketing programs would have. The demand generated by all BioNews platforms accounted for approximately 60% of our revenue in 2014. Because of the success we had, we are now using BioNews to expand our market share on existing product lines as well as using their platforms to introduce new products in new markets.
BioNews has been an integral part of our clinical trial recruiting strategy from direct patient enrollment to overall trial awareness. We were impressed by the speed with which they launched our campaign and were even more impressed by how quickly we realized results. We have since expanded our relationship with BioNews to engage with all therapeutic areas of our portfolio.